Variations in Practice Among Cirrhotic Patients With Portal Vein Thrombosis and Esophageal Varices: A North American Survey Study

被引：4

作者：

Mui, Brandon G. ^{[1
]}

Grinspan, Lauren T. ^{[2
,3
]}

Crismale, James F. ^{[2
,3
]}

机构：

[1] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA

[2] Icahn Sch Med Mt Sinai, Dept Med, Div Liver Dis, New York, NY USA

[3] Icahn Sch Med Mt Sinai, Recanati Miller Transplantat Inst, Dept Med, New York, NY USA

来源：

AMERICAN JOURNAL OF GASTROENTEROLOGY | 2024年 / 119卷 / 04期

关键词：

anticoagulation; splanchnic thrombosis; cirrhosis; portal hypertension; hemorrhage; ANTICOAGULATION; EFFICACY; SAFETY; DECOMPENSATION;

D O I：

10.14309/ajg.0000000000002640

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

INTRODUCTION:There exists variation regarding the approach to anticoagulation and variceal hemorrhage (VH) prophylaxis among patients with cirrhosis and portal vein thrombosis (PVT).METHODS:A survey was distributed to gastroenterology and hepatology providers to assess the approach to anticoagulation and VH prophylaxis among patients with PVT in cirrhotic patients.RESULTS:Providers were more likely to start anticoagulation if the patient was listed for liver transplantation, was symptomatic, or had superior mesenteric vein thrombosis. For prevention of first VH, many providers opt for combination therapy with both nonselective beta blockers and variceal ligation.DISCUSSION:Although providers agree on the clinical scenarios that merit initiation of anticoagulation, practice variation was identified in the means of preventing first VH.

引用

页码：774 / 777

页数：4

共 50 条

[31] Clinical outcomes of antithrombin III-based therapy for patients with portal vein thrombosis: A retrospective, multicenter study [J].

Hayama, Korenobu ;

Atsukawa, Masanori ;

Tsubota, Akihito ;

Kondo, Chisa ;

Iwasa, Motoh ;

Hasegawa, Hiroshi ;

Takaguchi, Koichi ;

Tsutsui, Akemi ;

Uojima, Haruki ;

Hidaka, Hisashi ;

Okubo, Hironao ;

Suzuki, Tatsuya ;

Matsuura, Kentaro ;

Tada, Toshifumi ;

Kawabe, Naoto ;

Tani, Joji ;

Morishita, Asahiro ;

Ishikawa, Toru ;

Arase, Yoshitaka ;

Furuichi, Yoshihiro ;

Kato, Keizo ;

Kawata, Kazuhito ;

Chuma, Makoto ;

Nozaki, Akito ;

Hiraoka, Atsushi ;

Watanabe, Tsunamasa ;

Kagawa, Tatehiro ;

Toyoda, Hidenori ;

Taniai, Nobuhiko ;

Yoshida, Hiroshi ;

Tanaka, Yasuhito ;

Iwakiri, Katsuhiko .

HEPATOLOGY RESEARCH, 2023, 53 (01) :51-60

[32] Anticoagulation for portal vein thrombosis in cirrhotic patients should be always considered [J].

Marco Senzolo ;

Cecilia Ferronato ;

Patrizia Burra ;

Maria Teresa Sartori .

Internal and Emergency Medicine, 2009, 4 :161-162

[33] Portal vein thrombosis in cirrhotic patients - it is always the small pieces that make the big picture [J].

Girleanu, Irina ;

Trifan, Anca ;

Stanciu, Carol ;

Sfarti, Catalin .

WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (39) :4419-4427

[34] Transjugular intrahepatic portosystemic shunt creation for cirrhotic portal hypertension is well tolerated among patients with portal vein thrombosis [J].

Merola, Jonathan ;

Fortune, Brett E. ;

Deng, Yanhong ;

Ciarleglio, Maria ;

Amirbekian, Smbat ;

Chaudhary, Noami ;

Shanbhogue, Alampady ;

Ayyagari, Rajasekhara ;

Rodriguez-Davalos, Manuel I. ;

Teperman, Lewis ;

Charles, Hearns W. ;

Sigal, Samuel H. .

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 30 (06) :668-675

[35] Predicting the risk of variceal rehemorrhage in cirrhotic patients with portal vein thrombosis: A two-center retrospective study [J].

Zhang, Shuo ;

Zhong, Xuan ;

Zhong, Hui ;

Zhong, Lan ;

Li, Jing ;

Zhu, Feng Shang ;

Xia, Lu ;

Yang, Chang Qing .

JOURNAL OF DIGESTIVE DISEASES, 2023, 24 (11) :619-629

[36] Efficacy and safety of anticoagulation in asymptomatic cirrhotic patients with portal vein thrombosis: a systematic review and meta-analysis [J].

Wu, Qingping ;

Zhang, Xingfen ;

Xu, Anyi ;

Zhu, Sidong ;

Zhang, Xiaoming ;

Wu, Qi ;

Zhang, Shengying .

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2025, 60 (02) :197-207

[37] A single hospital study on portal vein thrombosis in cirrhotic patients - clinical characteristics & risk factors [J].

Chen, Huisong ;

Trilok, Goolab ;

Wang, Fei ;

Qi, Xiaolong ;

Xiao, Junjie ;

Yang, Changqing .

INDIAN JOURNAL OF MEDICAL RESEARCH, 2014, 139 :260-266

[38] Direct Oral Anticoagulants Versus Traditional Anticoagulation in Cirrhotic Patients with Portal Vein Thrombosis: Updated Systematic Review [J].

Xiao, Xiulin ;

Zhu, Wengen ;

Dai, Qixin .

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2024, 30

[39] Transjugular intrahepatic portosystemic shunt for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: study protocol for a randomised controlled trial [J].

Qi, Xingshun ;

He, Chuangye ;

Yin, Zhanxin ;

Wang, Zhengyu ;

Zhang, Hongbo ;

Yao, Liping ;

Wang, Jianhong ;

Xia, Jielai ;

Cai, Hongwei ;

Yang, Zhiping ;

Bai, Ming ;

Guo, Wengang ;

Niu, Jing ;

Wu, Kaichun ;

Fan, Daiming ;

Han, Guohong .

BMJ OPEN, 2013, 3 (07)

[40] Natural history and clinical outcomes in patients with portal vein thrombosis by etiology: A retrospective cohort study [J].

Acuna-Villaorduna, Ana ;

Tran, Vivy ;

Gonzalez-Lugo, Jesus D. ;

Azimi-Nekoo, Elham ;

Billett, Henny H. .

THROMBOSIS RESEARCH, 2019, 174 :137-140

← 1 2 3 4 5 →